Acadian Asset Management’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Acadian Asset Management’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,451	Closed	-$27K	–	2284
2021 Q1	$27K	Sell	2,451 -1,550	-39%	-$15K	﹤0.01%	1941
2020 Q4	$39K	Sell	4,001 -4,126	-51%	-$27K	﹤0.01%	2002
2020 Q3	$44K	Sell	8,127 -202	-2%	-$1.21K	﹤0.01%	1887
2020 Q2	$49K	Sell	8,329 -138	-2%	-$798	﹤0.01%	1927
2020 Q1	$31K	Buy	8,467 +6,526	+336%	+$33.8K	﹤0.01%	1597
2019 Q4	$12K	Hold	1,941	–	–	﹤0.01%	1750
2019 Q3	$27K	Hold	1,941	–	–	﹤0.01%	1689
2019 Q2	$29K	Buy	+1,941	New	+$52K	﹤0.01%	1558

Other funds holding FSTX

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

AVA

Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Acadian Asset Management's FSTX Position: Q2 2021 in Review

Acadian Asset Management sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q2 2021, closing a stake of 2,451 shares — an estimated $27K sold.

Acadian Asset Management first reported a position in FSTX in Q2 2019 and held it in 8 quarters. The position peaked at $49K in Q2 2020. 41 funds tracked by Wall St. Rank hold FSTX as of Q2 2021.

Acadian Asset Management reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Acadian Asset Management sold 2,451 F-star Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $27K.
Acadian Asset Management first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2019 and held it in 8 quarters.
Acadian Asset Management's F-star Therapeutics, Inc. Common Stock position peaked at $49K in Q2 2020.
41 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Acadian Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.